Kuehne + Nagel has secured the contract to manage the domestic road distribution of all of GlaxoSmithKline Plc’s fast-moving consumer and healthcare goods throughout the UK.
K+N will be responsible for the main inbound supply route from specific UK sites and the final-mile delivery of all subsequent outbound shipments.
This new agreement expands Kuehne + Nagel and GSK’s collaboration, comprising air, sea, overland services and Logistics Control Centres, having already signed a five-year end-to-end global logistics partnership in 2016. In the scope of this successfully implemented partnership, Kuehne + Nagel runs the core business of transporting products from the raw materials supplier to trade customers for GSK.
“Following the successful deployment of the air and seafreight operations into Kuehne + Nagel during 2016 as part of the end-to-end partnership with GSK, we are very pleased to now be awarded the overland distribution business, especially in the UK where the GSK journey began," said Marcus Bennett, National Manager of Kuehne + Nagel UK.
"By understanding the challenges facing customers and the increasing execution compliance standards required in the market, we offer GSK tailor-made solutions that provide a competitive advantage through supply chain efficiency. This expanded partnership will enable GSK to continue to develop and deliver their services, facilitating continued global growth through effective distribution of their fast-moving consumer and healthcare goods across the UK.
"The new cooperation highlights Kuehne + Nagel’s continued commitment to the pharma and health care industry, which is of strategical importance for us, strengthening our position as the market leader.”